This inventor holds 1 USPTO granted patent. Top assignee: Orion Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: The Innovations of Jeffrey Hosenpud
Introduction
Jeffrey Hosenpud is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of medicine, particularly in the treatment of cardiac conditions. His innovative approach has led to the development of a unique method for treating sick sinus syndrome.
Latest Patents
Hosenpud holds a patent for a method of treating sick sinus syndrome with levosimendan. This compound, known scientifically as (−)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, has previously been suggested for the treatment of congestive heart failure. His research indicates that it is also effective in treating sick sinus syndrome and/or sinoatrial conduction disorders. Hosenpud's patent portfolio includes 1 patent.
Career Highlights
Jeffrey Hosenpud is associated with Orion Corporation, where he continues to work on innovative medical solutions. His career is marked by a commitment to improving patient outcomes through research and development in cardiology.
Collaborations
Hosenpud has collaborated with notable colleagues, including Lasse Lehtonen and Mikhail Ruda. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Jeffrey Hosenpud's work exemplifies the impact of innovation in the medical field. His contributions to the treatment of sick sinus syndrome highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile